Quick Takeaways
- Octagon Capital Advisors LP filed SCHEDULE 13G/A for Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH).
- Disclosed ownership: 6.1%.
- Date of event: 30 Sep 2025.
Octagon Capital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH)
- Filing Manager
- Octagon Capital Advisors LP
- Reporting Manager
- Octagon Capital Advisors LP
- Symbol
- DNTH
- Shares outstanding
- 39,617,492 shares
- Disclosed Ownership
- 2,416,667 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:46:07 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 05 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Octagon Capital Advisors LP disclosed 6.1% ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 05 Feb 2025.
- Current filing was accepted on 14 Nov 2025, 16:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 6.1% | 2,416,667 | 0 | 2,416,667 | /s/ Ting Jia | Managing Member | |
| Octagon Investments Master Fund LP | 5.3% | 2,125,000 | 0 | 2,125,000 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Octagon Private Opportunities Fund II LP | 0.7% | 291,667 | 0 | 291,667 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Ting Jia | 6.1% | 2,416,667 | 0 | 2,416,667 | /s/ Ting Jia | Ting Jia |